Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Board Changes

10 Apr 2025 07:00

RNS Number : 3758E
Wilmington PLC
10 April 2025
 

10 April 2025

 

Wilmington plc

 

Board change

 

Wilmington plc (LSE: WIL, 'Wilmington', 'the Group'), the provider of data, information, education and training in the global Governance, Risk and Compliance markets, today announces that Martin Morgan will retire as Chair with effect from 23 June 2025 and will be replaced as Chair and as a director of the Group by Gordon Hurst from that date. Gordon will also join the Nomination and Remuneration Committees.

 

Gordon worked at Capita plc as Group Finance Director from 1996 to 2015 and has followed a plural non-executive career since then, including being Non-Executive Chair of Darktrace plc from 2021 to 2024, Azets from 2019 to 2023, Featurespace from 2014 to 2023 and Marston Holdings from 2016 to 2021 and a Non-Executive Director of Motorpoint plc from 2016 to 2021. Gordon is currently Non-Executive Chairman of Cadro Technologies (since May 2024) and Air IT (since August 2024).

 

Gordon is a qualified chartered accountant and member of the ICAEW.

 

Helen Sachdev, Senior Independent Director of Wilmington, said

 

"Gordon brings a wealth of experience and relevant expertise, from both his non-executive and his executive careers. We look forward to him joining the Board.

 

"On behalf of the Board, I'd like to thank Martin for his considerable contribution over seven years as Chair of Wilmington."

 

There are no additional disclosures required under Listing Rule 9.6.13 R (1) to (6) in relation to the appointment of Gordon Hurst.

 

For further information, contact:

Wilmington plc

Guy Millward, CFO and Company Secretary

 

Meare Consulting

Adrian Duffield

020 7490 0049

 

 

 

07990 858548

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the UK version of Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs over 650 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGGDDLLGKZM
Date   Source Headline
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:00 amRNSTransaction in Own Shares
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTotal Voting Rights - Replacement
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 20257:30 amRNSTotal Voting Rights
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 20257:00 amRNSTransaction in Own Shares
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSBoard Changes
9th Apr 20253:49 pmRNSSave As You Earn Options
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:05 amRNSTotal Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSAmendment to Transaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20252:19 pmRNSTotal Voting Rights
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.